Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316604 Interferon lambda fusion polypeptides
12/16/2010US20100316594 Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infections
12/16/2010US20100316529 Anti-Microbial Systems and Methods
12/16/2010DE102009019460A1 Use of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor for treatment and/or prevention of coxsackievirus infection and adenoviral infection or diseases caused by coxsackievirus and/or adenovirus e.g. myocarditis and pericarditis
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2785350A1 Il-17 for use in treating local infections in mammals
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010CA2765271A1 Silver hydrosol, dental application and other uses thereof
12/16/2010CA2764903A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
12/16/2010CA2764759A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010CA2764376A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
12/16/2010CA2764141A1 Heterocyclic antiviral compounds
12/16/2010CA2761121A1 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010CA2760887A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010CA2737601A1 Anti-viral compounds
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261349A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261348A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261347A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261346A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261345A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261344A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261343A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261342A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261341A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261340A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261339A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261338A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
12/15/2010EP2261251A2 Methods for the synthesis of a modified hemoglobin solution
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261238A1 Cyclic compound and salt thereof
12/15/2010EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260870A2 Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent
12/15/2010EP2260869A2 Pharmaceutical product
12/15/2010EP2260868A2 Methods for the treatment of an infectious bacterial disease with anti-lactone or lactone derived signal molecules antibody
12/15/2010EP2260863A1 Prophylactic/therapeutic agent for infectious disease
12/15/2010EP2260855A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same
12/15/2010EP2260849A1 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
12/15/2010EP2260848A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
12/15/2010EP2260847A1 Aqueous liquid containing gatifloxacin
12/15/2010EP2260832A2 Optimal polymer mixtures for gastric retentive tablets
12/15/2010EP2260048A1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
12/15/2010EP2260044A2 Thienopyrimidines
12/15/2010EP2259799A1 Combination of immunomodulator and anti-pathogenic agent
12/15/2010EP2259784A1 Composition and method for irrigation of a prepared dental root canal
12/15/2010EP2259772A2 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
12/15/2010EP1875910B1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine
12/15/2010EP1848723B1 New isothiazoloquinolones and related compounds as anti-infective agents
12/15/2010EP1748769B1 Antiviral composition comprising p-menthane-3,8-diol
12/15/2010EP1677808B1 Combined preparation for treating sepsis
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1501822B1 Phthalazinone derivatives
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010EP1353942B1 Peptide inhibitors of hiv entry
12/15/2010CN1969924B Pharmaceutical composition of Silibinin and isatis root
12/15/2010CN1956720B Combination medication for treating HIV infection
12/15/2010CN1899382B Method for preparing forsythia fruit effective part
12/15/2010CN1872166B Drop pills of magnolia vine fruit kernel and preparation method
12/15/2010CN1872161B Drop pills of Chaihuang, and preparation method
12/15/2010CN1857334B Glossy ganoderma spore oil emulsion for intravenous injection and its preparing method
12/15/2010CN1852920B Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/15/2010CN101918577A Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same
12/15/2010CN101918558A Treatment and prevention of influenza
12/15/2010CN101918440A Novel avian cytokines and genetic sequences encoding same
12/15/2010CN101918435A Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
12/15/2010CN101918417A Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same
12/15/2010CN101918416A Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
12/15/2010CN101918412A Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c
12/15/2010CN101918410A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
12/15/2010CN101918407A Beta-lactamase inhibitors
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101918028A Method of conferring a protective immune response to norovirus
12/15/2010CN101918014A Medicinal composition
12/15/2010CN101918012A Calcium-rich alkaline powder produced from processed molluse shells
12/15/2010CN101918005A An antimicrobial composition based on botanical extracts from oil palm vegetation liquor
12/15/2010CN101917984A Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals
12/15/2010CN101914564A Fusion of multiple enterotoxin genes of escherichia coli and application thereof
12/15/2010CN101914563A Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof
12/15/2010CN101914561A Fusion protein with antibacterial and repairing function and production method and application thereof
1 ... 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 ... 1798